An EU-funded project has advanced lung cancer research by focusing on its weak spot - the epigenetic (or non-inherited) changes that differentiate cancer cells from healthy cells, making them prime targets for new therapies and earlier detection. The project results are already contributing to clinical trials and new screening tools.from EUROPA - Syndicated Research News Feed http://ift.tt/1QkFCXt
via IFTTT
No comments:
Post a Comment